Cancer MDT meetings are a crucial point in a patient’s diagnosis to treatment journey where specialists gather to determine decisions on patient care. However, attendees recognise these meetings create inefficencies and overlook the patient voice. The Royal College of Radiologists (RCR) therefore set out to consult MDT members across the UK to help shape a reform process.
This consultation of staff surfaced the following headline findings and viewpoints:
Clear support for the clinical value of MDT meetings: ensuring best practice is followed, reducing unwarranted variation in care, enhancing communication within teams, reassuring staff about patient management decisions.
There are too many inefficiencies impacting these meetings, including; insufficient referral form details, repeat discussions, unavailable pathology results, and tech-availability issues.
Varying time burdens on staff from these meetings, with many serving on multiple MDT’s or pathways.
Clear priorities for improvement and a universal appetite for reform.
The reform of cancer MDT meetings has the potential to have an enormous impact on patient care and system productivity.
RCR are currently working with relevant stakeholders to determine next steps.
An academic paper is also due for publication in 2026, offering a descriptive analysis of:
